샘플 요청 목록

 카트 문의
시장보고서
상품코드
1794586

세계의 옥시토신 시장

Oxytocin
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 276 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

옥시토신 세계 시장은 2030년까지 1억 5,220만 달러에 달할 전망

2024년에 9,230만 달러로 추정되는 옥시토신 세계 시장은 2030년에는 1억 5,220만 달러에 달하고, 분석 기간 2024-2030년 CAGR은 8.7%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 산전은 CAGR 10.0%를 기록하며 분석 기간 종료시에는 1억 830만 달러에 달할 것으로 예측됩니다. 산후 부문의 성장률은 분석 기간 동안 CAGR 5.8%로 추정됩니다.

미국 시장은 2,520만 달러로 추정, 중국은 CAGR 13.7%로 성장 예측

미국의 옥시토신 시장은 2024년에 2,520만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간 2024년부터 2030년까지 13.7%의 CAGR로 성장하여 2030년에는 3,360만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 4.3%와 8.4%로 예측됩니다. 유럽에서는 독일이 CAGR 5.8%로 성장할 것으로 예측됩니다.

세계의 옥시토신 시장 - 주요 동향과 촉진요인 정리

옥시토신이 임산부 건강관리 및 기타 분야에서 중요한 약물인 이유는 무엇일까?

옥시토신은 산부인과 의료에서 분만 유도, 산후 출혈 예방 및 치료, 분만 시 및 산후 자궁 수축 보조에 널리 사용되는 펩타이드 호르몬입니다. 산모 건강관리, 특히 저자원 환경에서 산모 사망의 주요 원인인 분만 후 출혈로 인한 사망률 감소에 중요한 역할을 하고 있습니다. 이 의약품은 출산 결과 개선의 중요성 때문에 WHO의 필수 의약품 목록에 포함되어 있습니다.

의약품 등급의 옥시토신은 보통 주사로 투여되기 때문에 안정성을 유지하기 위해 콜드체인 보관이 필요합니다. 병원, 산부인과 진료소, 숙련된 출산 도우미가 있는 지방 보건소에서 가장 많이 사용됩니다. 옥시토신은 주로 자궁 강장 효과로 알려져 있지만, 사회적 유대감, 스트레스 조절, 자폐스펙트럼장애 연구 등 행동과학에 대한 응용 가능성도 연구되고 있습니다. 그러나 이러한 응용은 아직 탐색적이며, 표준적인 임상 실습에 이르지 못했습니다.

제형, 유통, 보관, 접근성 및 유효성을 개선하기 위해 제형, 유통, 보관은 어떻게 진화하고 있는가?

표준 옥시토신 제제에는 효능을 유지하기 위해 2℃-8℃에서 보관해야 하는 주사액이 포함되어 있습니다. 이 요구사항은 신뢰할 수 있는 냉장시설이 없는 농촌 지역이나 자원이 부족한 지역에서는 문제가 될 수 있습니다. 이에 따라 열에 안정한 제제나 콜드체인 의존도를 낮추는 옥시토신 유사제제, 설하 투여 등 대체 제제에 대한 관심이 높아지고 있습니다.

접근성을 개선하기 위한 노력으로는 투약 실수와 오염을 최소화하는 단위 용량 프리필드 시린지 및 자동 비활성화 전달 장치의 기술 혁신을 들 수 있습니다. 새로운 포장 디자인은 현장에서의 사용성을 향상시키고, 세계 협력 이니셔티브는 특히 산모 사망률이 여전히 높은 사하라 사막 이남 아프리카와 아시아 일부 지역에서 공급망의 강인성을 확대하는 것을 목표로 하고 있습니다. 규제 프레임워크도 강화되어 옥시토신 제품의 품질이 보장되고 있습니다.

옥시토신은 어디에서 가장 널리 사용되고 있으며, 어떤 이해관계자가 유통을 주도하고 있는가?

옥시토신은 병원 분만병동, 산부인과 클리닉, 산부인과 응급센터에서 가장 많이 임상적으로 사용되고 있습니다. 공중보건 시스템과 비정부기구는 특히 국제 원조로 모자보건 프로그램이 지원되는 지역에서는 배포의 주요 촉진자입니다. 각국 보건부는 표준 분만 프로토콜의 일부로 산모 관리 키트에 옥시토신을 포함시키는 경우가 많습니다.

지역 수요는 임산부 사망률 감소가 공중보건의 최우선 과제인 개발도상국에서 가장 높습니다. 그러나 제품의 품질, 보관 조건, 의료 종사자 교육에 대한 편차가 있기 때문에 최적의 사용은 여전히 제한적입니다. 보다 발전된 의료 시스템에서는 옥시토신 사용이 광범위하고 규제되어 분만 시설 전체에서 일관된 접근이 가능합니다. 제약회사, 보건부, 기부자 자금에 의한 보건 프로그램은 여전히 조달 및 유통 전략의 핵심적인 역할을 담당하고 있습니다.

옥시토신 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다.

옥시토신 시장의 성장은 임산부 건강에 대한 전 세계적인 관심 증가, 응급 산부인과 의료에 대한 투자 확대, 외과적 개입에 대한 접근성이 제한된 지역의 출산율 증가 등의 요인에 의해 주도될 것으로 예상됩니다. 산후 출혈을 줄이기 위한 임상 지침의 업데이트와 조산사 교육 확대 등 산후 출혈을 줄이기 위한 노력은 출산 치료의 최전선에서 옥시토신의 역할을 강화하고 있습니다.

저자원 환경에서의 접근성을 개선하는 열 안정성 제제의 개발로 수요가 더욱 뒷받침되고 있습니다. 국제보건기구가 지원하는 조달 프로그램은 공급 및 품질 보증 메커니즘을 확장하고 있습니다. 규격 미달 제품을 제거하기 위한 규제 개혁과 각국의 보건의료 프로토콜에 옥시토신이 광범위하게 포함되면서 세계 시장의 성장을 계속 뒷받침하고 있습니다.

부문

적응증(산전, 산후), 유통 채널(병원 약국, 드럭스토어 유통 채널, 온라인 유통 채널)

조사 대상 기업 사례

  • Alembic Pharmaceuticals Ltd.
  • Amneal Pharmaceuticals, Inc.
  • Bayer AG
  • BioPharma Laboratories
  • Cipla Limited
  • Endo International plc
  • Fresenius Kabi
  • GlaxoSmithKline plc(GSK)
  • Halewood Laboratories Pvt. Ltd.
  • Hikma Pharmaceuticals plc
  • Intas Pharmaceuticals Ltd.
  • Mylan N.V.(Now part of Viatris)
  • Novartis AG
  • Pfizer Inc.
  • ProSpec-Tany Technogene Ltd.
  • Rusan Pharma Ltd.
  • Sandoz(a Novartis division)
  • Shanghai Cisen Pharmaceutical Co.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계 고유의 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.28

Global Oxytocin Market to Reach US$152.2 Million by 2030

The global market for Oxytocin estimated at US$92.3 Million in the year 2024, is expected to reach US$152.2 Million by 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Antepartum, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$108.3 Million by the end of the analysis period. Growth in the Postpartum segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$25.2 Million While China is Forecast to Grow at 13.7% CAGR

The Oxytocin market in the U.S. is estimated at US$25.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$33.6 Million by the year 2030 trailing a CAGR of 13.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 8.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Oxytocin Market - Key Trends & Drivers Summarized

Why Is Oxytocin a Vital Drug in Maternal Healthcare and Beyond?

Oxytocin is a peptide hormone used extensively in obstetric care to induce labor, prevent and treat postpartum hemorrhage, and assist in uterine contraction during and after childbirth. It plays a critical role in maternal healthcare, particularly in reducing mortality from postpartum bleeding-a leading cause of maternal death in low-resource settings. The drug is included in the WHO’s list of essential medicines due to its significance in improving birth outcomes.

Pharmaceutical-grade oxytocin is typically administered via injection, requiring cold-chain storage to maintain stability. Its usage is most common in hospitals, maternity clinics, and rural health centers with skilled birth attendants. While primarily known for its uterotonic effects, oxytocin has also been investigated for potential applications in behavioral science, including studies on social bonding, stress regulation, and autism spectrum disorders. However, such applications remain exploratory and not yet standard clinical practice.

How Is Formulation, Distribution, and Storage Evolving to Improve Access and Efficacy?

Standard oxytocin formulations include injectable solutions that must be stored between 2°C and 8°C to retain potency. This requirement poses challenges in rural or under-resourced regions lacking reliable refrigeration. As a result, there is increasing interest in heat-stable formulations and alternatives such as oxytocin analogs or sublingual options that reduce cold-chain dependency.

Efforts to improve access include innovations in unit-dose prefilled syringes and auto-disable delivery devices that minimize dosing errors and contamination. New packaging designs are enhancing usability in field settings, while collaborative global initiatives aim to expand supply chain resilience, particularly in sub-Saharan Africa and parts of Asia where maternal mortality remains high. Regulatory frameworks are also being strengthened to ensure the quality of oxytocin products, as substandard formulations have posed safety risks in certain markets.

Where Is Oxytocin Most Widely Used and Which Stakeholders Are Driving Distribution?

Oxytocin sees its highest clinical use in labor wards of hospitals, maternity clinics, and emergency obstetric care centers. Public health systems and non-governmental organizations are key facilitators of distribution, particularly in regions where maternal health programs are supported by international aid. National health ministries often include oxytocin in maternal care kits as part of standard delivery protocols.

Regional demand is highest in developing countries, where maternal mortality reduction is a public health priority. However, inconsistencies in product quality, storage conditions, and healthcare worker training still limit optimal usage. In more developed healthcare systems, oxytocin use is widespread and regulated, with consistent access across birthing facilities. Pharmaceutical companies, health ministries, and donor-funded health programs remain central players in procurement and distribution strategies.

Growth in the Oxytocin market is driven by several factors…

Growth in the oxytocin market is driven by factors such as increasing global emphasis on maternal health, expanded investment in emergency obstetric care, and rising birth rates in regions with limited access to surgical interventions. Efforts to reduce postpartum hemorrhage, including updated clinical guidelines and expanded midwife training, are reinforcing oxytocin's role in frontline childbirth care.

Demand is further supported by development of heat-stable formulations that improve access in low-resource settings. Procurement programs backed by international health organizations are scaling up supply and quality assurance mechanisms. Regulatory reforms to eliminate substandard products, combined with broader inclusion of oxytocin in national health protocols, continue to support market growth globally.

SCOPE OF STUDY:

The report analyzes the Oxytocin market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Indication (Antepartum, Postpartum); Distribution Channel (Hospital Pharmacies, Drug Stores Distribution Channel, Online Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Alembic Pharmaceuticals Ltd.
  • Amneal Pharmaceuticals, Inc.
  • Bayer AG
  • BioPharma Laboratories
  • Cipla Limited
  • Endo International plc
  • Fresenius Kabi
  • GlaxoSmithKline plc (GSK)
  • Halewood Laboratories Pvt. Ltd.
  • Hikma Pharmaceuticals plc
  • Intas Pharmaceuticals Ltd.
  • Mylan N.V. (Now part of Viatris)
  • Novartis AG
  • Pfizer Inc.
  • ProSpec-Tany Technogene Ltd.
  • Rusan Pharma Ltd.
  • Sandoz (a Novartis division)
  • Shanghai Cisen Pharmaceutical Co.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Oxytocin - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Birth Rates and Institutional Deliveries Spur Demand for Oxytocin in Labor Induction and Postpartum Hemorrhage Management
    • WHO Recommendations and National Maternal Health Policies Strengthen Use of Oxytocin in Obstetric Protocols
    • Growing Awareness of Postpartum Hemorrhage (PPH) as a Leading Cause of Maternal Mortality Throws the Spotlight on Reliable Uterotonics
    • Expansion of Healthcare Access in Low- and Middle-Income Countries Supports Demand for Affordable Oxytocin Formulations
    • Technological Advancements in Heat-Stable Oxytocin Products Enhance Distribution in Resource-Limited Settings
    • Government and NGO-Led Maternal Health Programs Drive Volume Procurement Through Public Health Channels
    • Rising Adoption of Oxytocin in Cesarean Deliveries Boosts Usage in Surgical Maternity Care
    • Challenges in Cold Chain Maintenance Accelerate Demand for Thermostable or Injectable Oxytocin Alternatives
    • Regulatory Focus on Drug Quality and Authenticity Promotes Market Consolidation and GMP Compliance
    • Increased Clinical Trials on Sublingual and Intranasal Oxytocin Explore Non-Invasive Delivery Innovations
    • Growing Demand for Combination Uterotonic Therapies Encourages Co-Formulation with Other Maternal Health Drugs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Oxytocin Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Oxytocin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Oxytocin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Oxytocin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Antepartum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Antepartum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Antepartum by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Postpartum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Postpartum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Postpartum by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Drug Stores Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Drug Stores Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Drug Stores Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Oxytocin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • JAPAN
    • Oxytocin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • CHINA
    • Oxytocin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • EUROPE
    • Oxytocin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Oxytocin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Oxytocin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Oxytocin by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • FRANCE
    • Oxytocin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • GERMANY
    • Oxytocin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Oxytocin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Oxytocin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Oxytocin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Oxytocin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Oxytocin by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Oxytocin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • INDIA
    • Oxytocin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Oxytocin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Oxytocin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Oxytocin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Oxytocin by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Oxytocin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Oxytocin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Oxytocin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Oxytocin by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • AFRICA
    • Oxytocin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Oxytocin by Indication - Antepartum and Postpartum - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Oxytocin by Indication - Antepartum and Postpartum Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Oxytocin by Indication - Percentage Breakdown of Value Sales for Antepartum and Postpartum for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Oxytocin by Distribution Channel - Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Oxytocin by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제